2021-01-13 19:21:00| Fool.com Headlines
The company gave a sneak peek into its fourth-quarter financial results.
2021-01-12 21:51:00| Fool.com Headlines
When it comes to countering a key trick that cancer plays on the human immune system, this biotech has no equal.
2021-01-12 12:51:00| Fool.com Headlines
Only if its COVID-19 vaccine proves to be at least as effective than those developed by its rivals.
2021-01-10 13:56:00| Fool.com Headlines
Disappointing trial results caused a flock of analysts to drop their ratings on this biotech stock.
2021-01-08 18:49:00| Fool.com Headlines
The company is experiencing regulatory headwinds.